No Data
Shenghe Biotech-B (02898.HK) will hold a board of directors meeting on August 30th to approve the interim performance.
Shenghe Bio-B (02898.HK) announced that the company will hold a board of directors meeting on August 30, 2024 to approve the interim performance of the company and its subsidiaries for the six months ending June 30, 2024, as well as its publication.
SUNHO BIO-B: NOTICE OF BOARD MEETING
Sunho Biologics' Unit Enters Subscription Letters
Shenghe Biotech-B (02898) associated with the proposed subscription fund.
Shenghe Biotech-B (02898) issued an announcement on the Smart Finance app that on June 28, 2024, its indirect wholly-owned subsidiary Sunho HK (as a subscriber) entered into a subscription letter. Sunho HK agrees to subscribe to the funds (North Rock, Prudent Wealth, and Vanguard) according to the terms of the subscription letter. In order to improve fund efficiency and increase fund operating returns, the group will reasonably use its surplus cash to subscribe to these funds for financial management purposes to earn additional income without affecting normal operations.
Hong Kong Shares End Week in Red; Sunho Biologics Gains in Debut
Sunho Biologics Shares Rise 7% in Hong Kong Debut
No Data
